Allen S. Melemed

This profile gathers the share dealings of Allen S. Melemed in Chimerix Inc. Between 17 January 2023 and 21 April 2025, the trades on record add up to 5 filings.

No open-market purchase appears, only 1 sale worth €13k. Outside the open market, there are 3 share grants. In 2025 alone, the filings show no purchases and 1 sale.

The record was last updated on 21 April 2025 with a transaction (€1.3M) in Chimerix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.